Search results
Results from the WOW.Com Content Network
Glossophobia or speech anxiety is the fear of public speaking. [1] The word glossophobia derives from the Greek γλῶσσα glossa (tongue) and φόβος phobos (fear or dread.) The causes of glossophobia are uncertain but explanations include communibiology and the illusion of transparency .
An article based on a National Comorbidity Survey reported that 1/3 of people with lifetime social phobia had glossophobia [11] Another survey of a community sample from a Canadian city reported that of people who believed being anxious in one or several social situations 55% feared speaking to a large audience, 25% feared speaking to a small ...
An anxiolytic (/ ˌ æ ŋ k s i ə ˈ l ɪ t ɪ k, ˌ æ ŋ k s i oʊ-/; also antipanic or anti-anxiety agent) [1] is a medication or other intervention that reduces anxiety. This effect is in contrast to anxiogenic agents which increase anxiety.
Such visits for anxiety disorders tripled, from 1.4% during the earliest time period studied, to 4.2% during the last time period. This finding echoes multiple other studies showing dramatic ...
For premium support please call: 800-290-4726 more ways to reach us
In September 2023, Frontiers in Public Health published a systematic review and meta-analysis of 37 studies comprising 36,013 subjects aged 14 to 24 years that found a positive and statistically significant association between problematic internet use and social anxiety, [61] while BJPsych Open published a systematic review of 140 studies ...
The most known example for context anxiety is public speaking; almost 70% of students have a certain level of communication apprehension triggered by public speaking. [6] There are other contexts that can create a similar response such as speaking in front of class, small group discussions, or meetings. [5]
Buspirone, sold under the brand name Buspar among others, is an anxiolytic, a medication primarily used to treat anxiety disorders, particularly generalized anxiety disorder (GAD). [ 10 ] [ 11 ] It is a serotonin 5-HT 1A receptor partial agonist , increasing action at serotonin receptors in the brain. [ 3 ]